Cardiovascular diseases (CVDs), including a series of pathological disorders, severely
affect millions of people all over the world. To address this issue, several potential therapies …

Editorial Paul the encapsulated drug at injected site. In general, therapeutic approaches of
injectable hydrogels mainly include epicardial and endocardial injections. Main benefits of …

Heart failure still represents the leading cause of death worldwide. Novel strategies using
stem cells and growth factors have been investigated for effective cardiac tissue …

Heart failure (HF) affects 60 million people worldwide and has developed into a global
public health problem surpassing cancer and urgently needs to be solved. According to the …

Cardiac tissue damage due to myocardial infarction (MI) is one of the leading causes of
mortality worldwide. The available treatments of MI include pharmaceutical therapy, medical …

Tissue engineering promises to be an effective strategy that can overcome the lacuna
existing in the current pharmacological and interventional therapies and heart …

Myocardial infarction (MI) has become one of the serious diseases threatening human life
and health. However, traditional treatment methods for MI have some limitations, such as …

Although some advanced treatments of heart failure (HF) have experienced great
development in recent decades, morbidity and mortality associated with HF have not …

In this contribution, an injectable hydrogel was developed with chitosan, gelatin, β-
glycerphosphate and Arg-Gly-Asp (RGD) peptide: this hydrogel is liquid in room temperature …

Cardiovascular diseases (CVDs) pose a serious threat to human health, which are
characterized by high disability and mortality rate globally such as myocardial infarction (MI) …